Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Stimulating”

82 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 82 results

Not applicableStudy completedNCT04695626
What this trial is testing

Prospective Randomized Controled Study on the Outcome of Greenhouse Tec in the Arthroscopic Treatment of Small to Medium Rotator Cuff Tear

Who this might be right for
Bone Marrow StimulatingModified Suture Bridge
Beijing Jishuitan Hospital 72
Testing effectiveness (Phase 2)Ended earlyNCT00002778
What this trial is testing

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Large-scale testing (Phase 3)Study completedNCT02993510
What this trial is testing

Controlled Trial Comparing Chondro-Gide® to Microfracture Alone for Treatment of Knee Cartilage Defects.

Who this might be right for
Cartilage InjuryOsteochondritis Dissecans
Geistlich Pharma AG 67
Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Not applicableUnknownNCT04475341
What this trial is testing

Osteochondral Lesions Under 15mm2 of the Talus; is Iliac Crest Bone Marrow Aspirate Concentrate the Key to Success?

Who this might be right for
Osteochondral Lesion of Talus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 96
Testing effectiveness (Phase 2)Ended earlyNCT01222195
What this trial is testing

Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00011934
What this trial is testing

Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia

Who this might be right for
Leukemia
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Post-approval studies (Phase 4)Study completedNCT00126100
What this trial is testing

Bone Marrow Stem Cell Mobilisation Therapy for Acute Myocardial Infarction (AMI)(REVIVAL-2)

Who this might be right for
Myocardial Infarction
Deutsches Herzzentrum Muenchen 114
Not applicableStudy completedNCT05803681
What this trial is testing

CCEF in the Treatment of Acute VFFs: Randomized Controlled Trial

Who this might be right for
Vertebral FractureOsteoporotic Fractures
University of Bari Aldo Moro 70
Testing effectiveness (Phase 2)Study completedNCT00520468
What this trial is testing

Treatment of Myelodysplastic Syndrome (MDS) With Cytokine-Immunotherapy for Low-Risk MDS

Who this might be right for
Myelodysplastic Syndrome
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)Study completedNCT00135928
What this trial is testing

Stem Cells in Myocardial Infarction

Who this might be right for
Acute Myocardial Infarction
Rigshospitalet, Denmark 78
Testing effectiveness (Phase 2)Ended earlyNCT01034657
What this trial is testing

LBH589 Alone or in Combination With Erythropoietin Stimulating Agents (ESA) in Patients With Low or Int-1 Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndrome (MDS)
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Active Not RecruitingNCT02598661
What this trial is testing

Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
Geron Corporation 289
Not applicableLooking for participantsNCT00001529
What this trial is testing

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

Who this might be right for
Graft-Versus-Host DiseaseGraft-versus-leukemiaDonor Apheresis
National Heart, Lung, and Blood Institute (NHLBI) 500
Testing effectiveness (Phase 2)Study completedNCT01015352
What this trial is testing

Azacitidine Combined to Epoetin Beta in International Prognostic Scoring System (IPSS) Low-risk and Intermediate-1 Myelodysplastic Syndrome (MDS) Patients, Resistant to Erythropoetin-stimulating Agents (ESA)

Who this might be right for
Myelodysplastic Syndromes
Groupe Francophone des Myelodysplasies 98
Not applicableStudy completedNCT06851065
What this trial is testing

Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Patients With Lower-Risk Myelodysplastic Syndromes in the United States

Who this might be right for
Myelodysplastic Syndromes
Bristol-Myers Squibb 418
Testing effectiveness (Phase 2)UnknownNCT03356080
What this trial is testing

DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Shanghai Tong Ren Hospital 50
Not applicableStudy completedNCT03208803
What this trial is testing

Combination of JAK2 Inhibitor and Erythropoiesis-stimulating Agent in Myelofibrosis

Who this might be right for
Myelofibrosis; Anemia
Centre Hospitalier Annecy Genevois 65
Large-scale testing (Phase 3)Ended earlyNCT01987596
What this trial is testing

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

Who this might be right for
Childhood Choroid Plexus TumorChildhood MedulloblastomaChildhood Pineoblastoma+8 more
Barbara Ann Karmanos Cancer Institute 23
Very early researchStudy completedNCT02181478
What this trial is testing

Intra-Osseous Co-Transplant of UCB and hMSC

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+9 more
Case Comprehensive Cancer Center 6
Load More Results